David Redfern
Fortune : 6 M $ au 31/05/2026
Fortune : 6 M $ au 31/05/2026
David Simon Redfern currently works at ViiV Healthcare Ltd., as Chairman from 2011, Human Genome Sciences, Inc., as Director from 2012, Aspen Pharmacare Holdings Ltd., as Non-Executive Director from 2015, Haleon UK Holdings Ltd., as Director, and GSK Plc, as President-Corporate Development.
Mr. Redfern also formerly worked at Haleon UK Holdings (No.2) Ltd., as Director from 2019 to 2022, GlaxoSmithKline South Africa (Pty) Ltd., as Finance Director-European Business, and PricewaterhouseCoopers Services Ltd., as Principal.
Mr. Redfern received his undergraduate degree from the University of Bristol.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GSK PLC 0,01 % | 09/06/2026 | 218 610 ( 0,01 % ) | 6 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/05/2008 |
| ASPEN PHARMACARE HOLDINGS LIMITED | Directeur/Membre du Conseil | 01/02/2015 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Président | 01/04/2011 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Directeur/Membre du Conseil | 30/07/2012 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 18/07/2022 |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Corporate Officer/Principal | - |
PricewaterhouseCoopers Services Ltd.
PricewaterhouseCoopers Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, bookkeeping, business consulting and tax advisory services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Health Technology |
PricewaterhouseCoopers Services Ltd.
PricewaterhouseCoopers Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, bookkeeping, business consulting and tax advisory services | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national